[jimjamuser]

Originally Posted by Win1894

Each sovereign nation has the responsibility to review on its own terms, by its own standards, and by its own regulatory agency any application for a market approval of a new drug (vaccine) in that nation. The main component of that review is the clinical study conducted by the drug sponsor. Many other factors are involved in that review process such as the indications, contraindications, warnings and cautions, all this sometimes refered to as the IFU (indications for use) and labelling for the drug. None of this has anything to do with 'death panels'. The primary issues for the FDA are the safety and efficacy of the new drug. All these factors can be different in each country so both the date of submission of the sponsor's application and the length of time for review can be significantly different. None of this is a political matter. After regulatory approval the distribution and sequence of treatment will be conducted mostly a logical order based primarily on the sponsor's ability to manufacture and supply the vaccine.

That was extremely informative! And I believe that the Winchester 1894 was the rifle that won the West - very historic reference!